Hepatocellular Carcinoma (HCC)
Conditions
Interventions
Training Set:Postoperative observation
Validation Set:Postoperative observation
Sponsors
The First Affiliated Hospital of Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Patients who only accept radical liver resection as the sole treatment method; 2. Have not received transcatheter arterial chemoembolization (TACE), targeted therapy, or immunotherapy before the surgery; 3. Have been diagnosed as hepatocellular carcinoma through preoperative imaging examinations (enhanced CT/magnetic resonance imaging) or postoperative pathology, strictly in accordance with the "Standard for diagnosis and treatment of primary liver cancer (2024 edition)" ; 4. No evidence of extrahepatic metastasis was found in the preoperative imaging examinations; 5. Have no autoimmune diseases. 6. The patient is aged between 18 and 85 years old.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. Individuals with autoimmune diseases; 3. Patients with other malignant tumors; 4. Those who have previously received systemic treatment for liver cancer: traditional Chinese medicine, targeted therapy, immunotherapy, etc.; 5. Patients who have previously undergone surgical treatment: liver resection, ablation, TACE, etc.; 6. Patients who have experienced severe allergic reactions to chemotherapy drugs; 7. Unpredictable physical damage.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence-free survival;Brier Score;AUC;C-index;Sensitivity;Specificity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Alkaline Phosphatase, ALP;Albumin, ALB;Hepatitis;Platelet Count, PLT;Aspartate Aminotransferase, AST;Capsule invasion;Microvascular invasion;Fibrinogen, FIB;Alpha-fetoprotein, AFP;Blood loss;Prothrombin Time, PT;Hemoglobin (Hb);Tumor Diameter;Activated Partial Thromboplastin Time, APTT;Cirrhosis;Red Blood Cell Count, RBC;International Normalized Ratio, INR;White Blood Cell Count, WBC;Total Bilirubin, TBIL;Gamma-Glutamyl Transferase (GGT);Direct Bilirubin, DBIL;Total Protein (TP); | — |
Countries
China
Contacts
Public ContactZheng Xin
The First Affiliated Hospital of Xi'an Jiaotong University
Outcome results
None listed